Skip to main content
Log in

High Prevalence of Silent Brain Infarction in Patients Presenting with Mechanical Heart Valve Thrombosis

  • Short Communication
  • Published:
American Journal of Cardiovascular Drugs Aims and scope Submit manuscript

Abstract

Background: Symptomatic thromboembolic events including stroke occur frequently in patients with mechanical heart valves, particularly among those who are poorly anticoagulated.

Objective: This study set out to determine the prevalence of silent brain infarction (SBI) in this population.

Methods: This was a post hoc analysis of data from a randomized controlled trial carried out in a tertiary-care academic medical center. The trial included participants from a randomized controlled trial of fibrinolytic therapy (FT) in patients with left-sided prosthetic valve thrombosis (PVT), who had undergone pre-treatment computed tomography (CT) scans of the brain. The prevalence of SBI in this population was investigated.

Main Outcome Measure: Prevalence of silent brain infarction.

Results: Silent brain infarction was present in 27 of 72 patients (37.5%; 95% confidence interval [CI] 27.2, 49.1). Most patients with SBI (57; 82.6%) had sub-therapeutic anticoagulation at presentation. We identified baseline characteristics that were associated with the presence of SBI using a logistic regression model. Atrial fibrillation (AF) was strongly associated with the presence of SBI (odds ratio [OR] 5.60; 95% CI 1.32, 23.87; p= 0.02).

Conclusion: The high prevalence of SBI among this cohort of young patients with mechanical heart valves is alarming and calls for urgent efforts to improve the quality of anticoagulation.

Clinical Trial Registration: Registered in the US National Institutes of Health registry at http://clinicaltrials.gov as NCT00232622.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II

References

  1. Vermeer SE, Longstreth Jr WT, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007 Jul; 6 (7): 611–9

    Article  PubMed  Google Scholar 

  2. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994 Feb; 89 (2): 635–41

    Article  PubMed  CAS  Google Scholar 

  3. Edmunds Jr LH. Thromboembolic complications of current cardiac valvular prostheses. Ann Thorac Surg 1982 Jul; 34 (1): 96–106

    Article  PubMed  Google Scholar 

  4. Burchfiel CM, Hammermeister KE, Krause-Steinrauf H, et al. Left atrial dimension and risk of systemic embolism in patients with a prosthetic heart valve. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. J Am Coll Cardiol. 1990 Jan; 15 (1): 32–41

    CAS  Google Scholar 

  5. Karthikeyan G, Math RS, Mathew N, et al. Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a randomized controlled trial. Circulation 2009 Sep 22; 120 (12): 1108–14

    Article  PubMed  CAS  Google Scholar 

  6. Akdemir I, Dagdelen S, Yuce M, et al. Silent brain infarction in patients with rheumatic mitral stenosis. Jpn Heart J 2002 Mar; 43 (2): 137–44

    Article  PubMed  Google Scholar 

  7. Bernick C, Kuller L, Dulberg C, et al. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology 2001 Oct 9; 57 (7): 1222–9

    Article  PubMed  CAS  Google Scholar 

  8. Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003 May; 34 (5): 1126–9

    Article  PubMed  Google Scholar 

  9. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003 Mar 27; 348 (13): 1215–22

    Article  PubMed  Google Scholar 

  10. Wallentin L, Yusuf S, Ezekowitz MD, et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 2010 Sep 18; 376 (9745): 975–83

    Article  PubMed  CAS  Google Scholar 

  11. Talwar S, Kapoor CK, Velayoudam D, et al. Anticoagulation protocol and early prosthetic valve thrombosis. Indian Heart J 2004 May–Jun; 56 (3): 225–8

    PubMed  Google Scholar 

Download references

Acknowledgments

None of the authors have any competing interests. AR and RV contributed equally to this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ganesan Karthikeyan MD, DM, MSc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barwad, P., Raheja, A., Venkat, R. et al. High Prevalence of Silent Brain Infarction in Patients Presenting with Mechanical Heart Valve Thrombosis. Am J Cardiovasc Drugs 12, 345–348 (2012). https://doi.org/10.1007/BF03261843

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03261843

Keywords

Navigation